Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relationship between plasma and cellular potassium content during potassium repletion

S L Carney, T O Morgan

    The Medical Journal of Australia
    |September 5, 1981
    PubMed
    Summary

    Potassium repletion therapy normalized plasma potassium levels but not total body content in hypokalaemia patients. Renal function parameters remained depressed, indicating cellular potassium

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Conflict of interest: will it ever end?

    Internal medicine journal·2012
    Same author

    e-Health: a step forward but not without risk.

    Internal medicine journal·2010
    Same author

    Basic concepts in meta-analysis: A primer for clinicians.

    International journal of clinical practice·2006
    Same author

    Medication accuracy and general practitioner referral letters.

    Internal medicine journal·2006
    Same author

    Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment.

    Neuroscience·2004
    Same author

    In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.

    European journal of pharmacology·2001

    Area of Science:

    • Nephrology
    • Endocrinology
    • Internal Medicine

    Background:

    • Hypokalaemia, a state of low potassium, can impair renal function.
    • Plasma potassium concentration is commonly used to assess potassium status.
    • Cellular potassium content's role in renal function is not fully understood.

    Purpose of the Study:

    • To evaluate the impact of potassium repletion on plasma and total body potassium.
    • To assess changes in renal function following potassium therapy.
    • To determine the relationship between plasma potassium, total body potassium, and renal function.

    Main Methods:

    • Seven hypokalaemic patients received potassium chloride for two weeks.
    • Plasma potassium concentration and total body potassium content were measured.

    Related Experiment Videos

  • Glomerular filtration rate, renal plasma flow, and maximal urinary concentration were assessed before and after therapy.

    • Main Results:

    • Plasma potassium normalized quickly, but total body potassium remained low.
    • Renal function parameters (GFR, RPF, maximal urinary concentration) did not improve despite normalized plasma potassium.
    • Depressed renal function correlated with cellular potassium depletion, not plasma levels.

    Conclusions:

    • Plasma potassium concentration is an unreliable indicator of total body potassium status.
    • Renal function impairment in hypokalaemia is linked to cellular potassium deficit.
    • Cellular potassium levels, rather than plasma levels, are critical for renal function maintenance.